Hot NewsUncatagorized2021.06.28 Manysamrt’s research appeared on Scientific Report on June, 2021.
2021.06.28 Manysamrt’s research appeared on Scientific Report on June, 2021.
The newest publication supported by Manysmart, The potential of adoptive transfer of γ9δ2 T cells to enhance blinatumomab’s antitumor activity against B-cell malignancy, now comes to Scientific Reports.
It strongly suggested human γ9δ2 T cells combined with CD19BiTE may provide an efficient therapy for CD19-positive B-cell cancers.
In other words, the technology of γ9δ2 T cell expansion from Manysmart fully fits the requirement of experiments and tests and the expanded γ9δ2 T cells still show a valuable anti-tumor property.